Lantheus Holdings (LNTH) Gross Profit Growth (3y) (2017 - 2026)
Lantheus Holdings (LNTH) Gross Profit Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.23% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.42% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.01% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 8.70% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.26% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 28.48% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.60% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 6.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.07% |
| Mar 31, 2026 | 44.16% |
| Dec 31, 2025 | 12.95% |
| Sep 30, 2025 | 14.68% |
| Jun 30, 2025 | 20.42% |
| Mar 31, 2025 | 22.57% |
| Dec 31, 2024 | 62.51% |
| Sep 30, 2024 | 78.37% |
| Jun 30, 2024 | 77.05% |
| Mar 31, 2024 | 80.64% |
| Dec 31, 2023 | 81.18% |
| Sep 30, 2023 | 76.67% |
| Jun 30, 2023 | 98.66% |
| Mar 31, 2023 | 26.58% |
| Dec 31, 2022 | 55.38% |
| Sep 30, 2022 | 52.48% |
| Jun 30, 2022 | 45.76% |
| Mar 31, 2022 | 43.06% |
| Dec 31, 2021 | 9.72% |
| Sep 30, 2021 | -1.67% |